Abstract
Recently we reported that SLC22A4 and RUNX1 are associated with rheumatoid arthritis (RA). SLC22A4 is an organic cation transporter with unknown physiological function, and RUNX1 is a hematological transcriptional regulator that has been shown to be responsible for acute myelogenic leukemia. It is suggested that the association of RUNX1 with RA is due to its regulation of expression of SLC22A4. Because the physiological function of SLC22A4 is still unclear, further investigation is needed into how SLC22A4 affects RA susceptibility. Although the association of RUNX1 with RA was identified as a regulatory factor of SLC22A4, it is possible that RUNX1 is a key molecule in autoimmunity, as it has been reported to be associated with systemic lupus erythematosus and psoriasis, two other autoimmune diseases.


Similar content being viewed by others
Abbreviations
- CBF :
-
Core-binding factor
- IL :
-
Interleukin
- IRF :
-
Interferon regulatory factor
- LD :
-
Linkage disequilibrium
- NCF :
-
Neutrophil cytosolic factor
- OCT :
-
Organic cation transporter
- PADI :
-
Peptidylarginine deiminase
- RA :
-
Rheumatoid arthritis
- SLE :
-
Systemic lupus erythematosus
- SNP :
-
Single nucleotide polymorphism
References
Seldin MF, Amos CI, Ward R, Gregersen PK (1999) The genetics revolution and the assault on rheumatoid arthritis. Arthritis Rheum 42:1071–1079
Goldbach-Mansky R et al. (2000) Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2:236–243
Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273:1516–1517
Tokuhiro S et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat Genet 35:341–348
Aho K, Koskenvuo M, Tuominen J, Kaprio J (1986) Occurrence of rheumatoid arthritis in a nationwide series of twins. J Rheumatol 13:899–902
Silman AJ et al. (1993) Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol 32:903–907
Jarvinen P, Aho K (1994) Twin studies in rheumatic diseases. Semin Arthritis Rheum 24:19–28
Wolfe F, Kleinheksel SM, Khan MA (1988) Familial vs sporadic rheumatoid arthritis: a comparison of the demographic and clinical characteristics of 956 patients. J Rheumatol 15:400–404
Deighton CM, Walker DJ, Griffiths ID, Roberts DF (1989) The contribution of HLA to rheumatoid arthritis. Clin Genet 36:178–182
Hasstedt SJ, Clegg DO, Ingles L, Ward RH (1994) HLA-linked rheumatoid arthritis. Am J Hum Genet 55:738–746
Nepom GT (1998) Major histocompatibility complex-directed susceptibility to rheumatoid arthritis. Adv Immunol 68:315–332
Reveille JD (1998) The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 10:187–200
Cornelis F et al. (1998) New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc Natl Acad Sci USA 95:10746–10750
Shiozawa S et al. (1998) Identification of the gene loci that predispose to rheumatoid arthritis. Int Immunol 10:1891–1895
Jawaheer D et al. (2001) A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am J Hum Genet 68:927–936
MacKay K et al. (2002) Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum 46:632–639
Ohnishi Y et al. (2001) A high-throughput SNP typing system for genome-wide association studies. J Hum Genet 46:471–477
Ozaki K et al. (2002) Functional SNPs in the lymphotoxin-alpha gene that are associated with susceptibility to myocardial infarction. Nat Genet 32:650–654
Suzuki A et al. (2003) Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34:395–402
Yamada R, Suzuki A, Chang X, Yamamoto K (2003) Peptidylarginine deiminase type 4: identification of a rheumatoid arthritis-susceptible gene. Trends Mol Med 9:503–508
Grunig G et al. (1998) Requirement for IL-13 independently of IL-4 in experimental asthma. Science 282:2261–2263
Rioux JD et al. (2001) Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease. Nat Genet 29:223–228
Mansur AH, Bishop DT, Markham AF, Britton J, Morrison JF (1998) Association study of asthma and atopy traits and chromosome 5q cytokine cluster markers. Clin Exp Allergy 28:141–150
Kauppi P. et al. (2001) A second-generation association study of the 5q31 cytokine gene cluster and the interleukin-4 receptor in asthma. Genomics 77:35–42
Lee JK, Park C, Kimm K, Rutherford MS (2002) Genome-wide multilocus analysis for immune-mediated complex diseases. Biochem Biophys Res Commun 295:771–773
Giallourakis C et al. (2003) IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. Am J Hum Genet 73:205–211
Nezu K et al. (1999) Thoracoscopic lung volume reduction surgery for emphysema. Evaluation using ventilation-perfusion scintigraphy. Jpn J Thorac Cardiovasc Surg 47:267–272
Tamai I et al. (2000) Molecular and functional characterization of organic cation/carnitine transporter family in mice. J Biol Chem 275:40064–40072
Tamai I et al. (2001) Na (+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney. Biochim Biophys Acta 1512:273–284
Nezu J et al. (1999) Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter. Nat Genet 21:91–94
Tamai I et al. (1997) Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1. FEBS Lett 419:107–111
Yabuuchi H et al. (1999) Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ther 289:768–773
Motohashi H et al. (2002) Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J Am Soc Nephrol 13:866–874
Wu X, et al. (1998) Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem 273:32776–32786
Roumier C et al. (2003) New mechanisms of AML1 gene alteration in hematological malignancies. Leukemia 17:9–16
Downing JR (2001) AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia. Leukemia 15:664–665
Coffman JA (2003) Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell Biol Int 27:315–324
Nucifora G, Rowley JD (1995) AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1–14
Romana SP et al. (1995) High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood 86:4263–4269
Osato M et al. (1999) Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2alphaB gene associated with myeloblastic leukemias. Blood 93:1817–1824
Niini T, Kanerva J, Vettenranta K, Saarinen-Pihkala UM, Knuutila S (2000) AML1 gene amplification: a novel finding in childhood acute lymphoblastic leukemia. Haematologica 85:362–366
Song WJ. et al. (1999) Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet 23:166–175
Prokunina L et al. (2002) A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666–669
Helms C et al. (2003) A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nat Genet 35:349–356
Surinya KH, Cox TC, May BK (1998) Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene. J Biol Chem 273:16798–16809
Ghayor C et al. (2000) Regulation of human COL2A1 gene expression in chondrocytes. Identification of C-Krox-responsive elements and modulation by phenotype alteration. J Biol Chem 275:27421–27438
Beohar N, Kawamoto S (1998) Transcriptional regulation of the human nonmuscle myosin II heavy chain-A gene. Identification of three clustered cis-elements in intron-1 which modulate transcription in a cell type- and differentiation state-dependent manner. J Biol Chem 273:9168–9178
Lutterbach B, Hiebert SW (2000) Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation. Gene 245:223–235
Olofsson P et al. (2003) Positional identification of Ncf1 as a gene that regulates arthritis severity in rats. Nat Genet 33:25–32
Peltekova VD, Wintle RF, Rubin LA et al. (2004) Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet 36:471–475
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yamada, R., Tokuhiro, S., Chang, X. et al. SLC22A4 and RUNX1: identification of RA susceptible genes. J Mol Med 82, 558–564 (2004). https://doi.org/10.1007/s00109-004-0547-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-004-0547-y